Clinical Trial Update: A Phase I Study of NTQ1062 in Chinese Patients With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

A Phase I clinical trial of NTQ1062 in Chinese patients with solid tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• NTQ1062

Snippet

Sponsor: Nanjing Chia-tai Tianqing Pharmaceutical | Conditions: Advanced Solid Tumors | Phase 1 | Status: COMPLETED